ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO1415

Siglec-9 Agonism Reduces ANCA-Mediated Neutrophil Responses In Vitro

Session Information

Category: Glomerular Diseases

  • 1202 Glomerular Diseases: Immunology and Inflammation

Authors

  • Kidder, Dana, NHS Grampian, Aberdeen, Aberdeen, United Kingdom
  • Nellany, Kristine, NHS Grampian, Aberdeen, Aberdeen, United Kingdom
  • Walls, Catriona, University of Aberdeen School of Medicine Medical Sciences and Nutrition, Aberdeen, Aberdeen, United Kingdom
Background

Sialic acid-binding Ig-like lectin 9 (Siglec-9) is constitutively expressed on neutrophils and monocytes. The expression and potential role of siglec-9 in ANCA-associated vasculitis (AAV) is yet to be determined. We aimed to examine the expression of siglec-9 in patients with AAV and explore the impact of siglec-9 agonism on ANCA-mediated neutrophil responses in vitro.

Methods

Leukocytes and serum were isolated from peripheral venous blood of AAV patients and siglec-9 expression was measured by flow cytometry and ELISA, respectively. Immunohistochemistry was performed on kidney biopsies of AAV patients with AAGN and stained for siglec-9 and leukocyte markers. Functional studies were done using healthy donor neutrophils in the presence of ANCA and siglec-9 mAb to investigate its role in apoptosis and ROS production.

Results

We found increased serum siglec-9 expression in active AAV compared to remission AAV and a positive correlation with disease activity. Neutrophils and intermediate (CD14+/CD16+) monocytes from PR3-ANCA patients displayed higher siglec-9 expression compared to MPO-ANCA patients. Siglec-9 expression in AAGN was restricted to areas of active inflammation. We observed increased siglec-9 shedding in neutrophils following ANCA stimulation. Siglec-9 agonism in these neutrophils was associated with increased apoptosis and reduced ROS production compared to isotype control and unstimulated neutrophils.

Conclusion

Our study suggests that siglec-9 is expression correlates with disease activity in AAV. Our functional studies support a potential role for siglec-9 in modulating ANCA-mediated neutrophil responses. Further evaluation is required to determine the relevance of these findings on neutrophil-endothelial interactions.

Funding

  • Government Support – Non-U.S.